About MedPlus
MedPlus is a company based in Hyderabad (India) founded in 2006 by Gangadi Madhukar Reddy. It operates as a Direct-to-Consumer (D2C) and Two-Sided Marketplace. MedPlus has raised $268.78 million across 10 funding rounds from investors including Goldman Sachs, Warburg Pincus and TVS Capital Funds. The company has 25,010 employees as of March 31, 2024. MedPlus offers products and services including Pharmacy Retail, MedPlus Mart, MedPlus Lens, and MedPlus Labs.
- Headquarter Hyderabad, India
- Employees 25010 as on 31 Mar, 2024
- Founders Gangadi Madhukar Reddy
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Medplus Health Services Ltd.
-
Annual Revenue
$718.22 M (USD)9.09as on Mar 31, 2025
-
Net Profit
$17.56 M (USD)129.59as on Mar 31, 2025
-
EBITDA
$57.35 M (USD)37.45as on Mar 31, 2025
-
Total Equity Funding
$268.78 M (USD)
in 10 rounds
-
Latest Funding Round
$78.76 M (USD), Series C
Feb 09, 2021
-
Investors
Goldman Sachs
& 19 more
-
Employee Count
25010
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of MedPlus
MedPlus is a publicly listed company on the NSE with ticker symbol MEDPLUS in India, operating in the Retail trade sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of MedPlus
MedPlus offers a comprehensive portfolio of products and services, including Pharmacy Retail, MedPlus Mart, MedPlus Lens, and MedPlus Labs.
Medicines are sold through retail pharmacy stores nationwide.
General goods are offered through an online platform.
Eyewear products are provided via online sales channels.
Lab services are accessible through online booking systems.
People of MedPlus
Unlock access to complete
Unlock access to complete
Funding Insights of MedPlus
MedPlus has successfully raised a total of $268.78M across 10 strategic funding rounds. The most recent funding activity was a Series C round of $78.76 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series C — $78.8M
-
First Round
First Round
(07 Feb 2007)
- Investors Count 20
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2021 | Amount | Series C - MedPlus | Valuation | Warburg Pincus , Premji Invest |
|
| Apr, 2019 | Amount | Series C - MedPlus | Valuation | Premji Invest |
|
| Jan, 2018 | Amount | Debt – Conventional - MedPlus | Valuation |
investors |
Investors in MedPlus
MedPlus has secured backing from 20 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Goldman Sachs, Warburg Pincus and TVS Capital Funds.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage private equity investments are pursued across diverse sectors.
|
Founded Year | Domain | Location | |
|
Provides venture capital for technology startups and enterprise innovations worldwide.
|
Founded Year | Domain | Location | |
|
Investment banking services are delivered across multiple financial sectors.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MedPlus
Financial Statements - MedPlus
Medplus Comparisons
Competitors of MedPlus
Latest news on Medplus
Frequently Asked Questions about MedPlus
MedPlus was founded in 2006 and raised its 1st funding round 1 year after it was founded.
MedPlus is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Gangadi Madhukar Reddy is the current CEO of MedPlus. They have also founded this company.
MedPlus is a funded company, having raised a total of $268.78M across 10 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $117.49M, raised on Feb 07, 2007.
As of Mar 31, 2024, the latest employee count at MedPlus is 25,010.
Annual revenue of MedPlus is $718.22M as on Mar 31, 2025.
MedPlus, operating as MedPlus Health Services Limited, is established as Indias second largest retail pharmacy network with over 4,230 stores across multiple states. The company is focused on providing genuine pharmaceutical products and fast-moving consumer goods at affordable prices. Stores are distributed across regions like Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal, Maharashtra, Kerala, Chhattisgarh, and Madhya Pradesh. Additionally, an omni-channel approach is adopted, integrating offline stores with online platforms such as MedPlus Mart, MedPlus Lens, and MedPlus Labs, accessible via website and mobile application. A customer loyalty program named FlexiRewards is also operated to enhance customer engagement through redeemable points.
MedPlus offers Pharmacy Retail, MedPlus Mart, MedPlus Lens, and MedPlus Labs.
Yes, MedPlus is publicly traded on NSE under the ticker symbol MEDPLUS.
MedPlus has 20 investors. Key investors include Goldman Sachs, Warburg Pincus, TVS Capital Funds, Premji Invest, and Merlin Holdings.
The ticker symbol of MedPlus is MEDPLUS on NSE.
The valuation of MedPlus is $224.8M as of Apr 2019.